Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 -- 1944 2022-08-12 06:17:44 |
2 format change Meta information modification 1944 2022-08-12 07:48:17 |

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Shoda, K.;  Kuwano, Y.;  Ichikawa, D.;  Masuda, K. Biological Roles of circRNAs. Encyclopedia. Available online: (accessed on 25 April 2024).
Shoda K,  Kuwano Y,  Ichikawa D,  Masuda K. Biological Roles of circRNAs. Encyclopedia. Available at: Accessed April 25, 2024.
Shoda, Katsutoshi, Yuki Kuwano, Daisuke Ichikawa, Kiyoshi Masuda. "Biological Roles of circRNAs" Encyclopedia, (accessed April 25, 2024).
Shoda, K.,  Kuwano, Y.,  Ichikawa, D., & Masuda, K. (2022, August 12). Biological Roles of circRNAs. In Encyclopedia.
Shoda, Katsutoshi, et al. "Biological Roles of circRNAs." Encyclopedia. Web. 12 August, 2022.
Biological Roles of circRNAs

Circular RNAs (circRNAs) comprise a large class of endogenous non-coding RNA with covalently closed loops and have independent functions as linear transcripts transcribed from identical genes. circRNAs are generated by a “back-splicing” process regulated by regulatory elements in cis and associating proteins in trans. Many studies have shown that circRNAs play important roles in multiple processes, including splicing, transcription, chromatin modification, miRNA sponges, and protein decoys. circRNAs are highly stable because of their closed ring structure, which prevents them from degradation by exonucleases, and are more abundant in terminally differentiated cells, such as brains.

circRNA biomarker therapeutic target

1. Introduction

Covalently closed circular RNAs (circRNAs) are a large class of non-coding RNAs that are generated by a process called back-splicing. In 1976, the first circular RNA molecule (viroid) was discovered as a pathogen by Sanger sequencing [1]. After a few years, Hsu et al. [2] reported the presence of the circular form of RNA in the cytoplasmic extraction of several eukaryotic cells using electron microscopy. Since then, a variety of circular RNAs have been reported. In 1991, Nigro et al. discovered some abnormally spliced transcripts called “scrambled exons”, which originated from the candidate tumor suppressor gene deleted in colorectal cancer (DCC) and were produced by non-canonical splicing [3]. A year later, similar transcripts from the human ETS proto-oncogene 1, transcription factor (ETS-1) gene were reported [4]. In 1993, Cocquerelle et al. identified that these mis-splicing products from the ETS-1 and DCC genes are circular RNA molecules containing only normally spliced exons and are localized in the cytoplasm [5]. The second report in 1993 demonstrated that the Sry RNA molecules in cDNA and 5′RACE clones isolated from mouse testes have a circular structure [6]. This circular RNA represents the most abundant transcript in the cytoplasm and testis, indicating that it might be functional. Several other studies have documented that exon circularization can be induced in nuclear extracts in vitro [7][8]. In recent years, the advancement of high-throughput RNA sequencing (RNA-seq) followed by bioinformatic algorithms specialized for circRNAs has identified thousands of circRNAs in metazoans, including Drosophila, nematodes, mice, and humans, and have shown their tissue- and developmental-specific expression pattern [9][10][11][12][13][14].
Most circRNAs are generated by back-splicing, in which a downstream splice donor site is covalently linked to an upstream splice-acceptor site, and are abundant in the cytoplasm. Bioinformatic algorithms that identified circRNAs from long-read RNA-seq data revealed that more than half of the circRNAs span <5 complete exons and consist of only protein-coding exons, especially in 5′-untranslated regions (UTRs) [15]. In contrast to exon-derived circRNAs, failure in intron lariat debranching or internal intron retention during canonical splicing may produce circular intronic RNAs (ciRNAs) and exon–intron circular RNAs (EIciRNAs), respectively. These classes of circRNAs are abundant in the nucleus and act as stimulators of the transcription of their parental genes in cis [16][17].
In general, circRNAs are highly stable because of the covalently closed ring structure that protects them from degradation by exonucleases [10] and are more abundant in terminally differentiated cells, such as brains [11]. In contrast, the expression levels of circRNAs in highly proliferating cells, such as cancer cells, are often low, possibly because of the thinning out by cell proliferation [18].

2. Biogenesis of circRNAs

Many studies have shown that circRNAs are expressed at much lower levels than their associated linear transcripts, and their expression levels do not simply correlate with their linear isoform expression, indicating a potential layer of unknown regulation [19]. Some studies have revealed that circRNA production strongly depends on the presence of canonical splice sites in bracketing exons and spliceosome assembly, indicating that circRNA biogenesis competes with the linear splicing of flanking exons during the canonical splicing machinery [20][21]. However, two reports have shown that depleting the splicing factors or components of U2 snRNPs increases the ratio of circRNAs to linear RNAs [22][23], indicating that the suppression or slowing of canonical pre-mRNA splicing machinery changes the steady-state production of linear transcripts to circular RNAs.
circRNA formation depends on two mechanisms. The first is base pairing between inverted repeat elements located in both the upstream and downstream introns [24]. In humans, 88% of these inverse-repeat elements are Alu repeats [10][25][26]. Double-stranded RNA (dsRNA)-specific adenosine deaminase (ADAR), which mediates adenosine to inosine editing in endogenous dsRNA, and DexH-Box helicase 9 (DHX9), which catalyzes the ATP-dependent unwinding of double-stranded RNA complexes, suppress the production of circRNAs that depend on base pairing between inverted repeats to prevent the looping of intron sequences [26][27]. In contrast, nuclear factor 90 (NF90) and 110 (NF110), both of which contain a nucleic acid-binding motif (double-stranded RNA-binding motif, dsRBM), promote the biogenesis of circRNAs by stabilizing the base pairing between inversed repeats. The second mechanism involves the dimerization of RNA-binding proteins (RBPs). Quaking (QKI), which belongs to the STAR family of KH domain-containing RBPs, is associated with regions containing recognition elements within a single RNA, resulting in the stimulation of circRNA production [28]. FUS, also known as hnRNPP2, binds to intron regions proximal to the splice junctions involved in circRNA formation and affects the back-splicing reaction [29]. The other RBP of the heterogeneous nuclear ribonucleoprotein family, hnRNPL, binds preferentially to CA-repeat or CA-enriched RNA motifs in introns, resulting in enhanced circulation [30].
After processing in the nucleus, most exon-derived circRNAs are exported into the cytoplasm. RNAi screening assays have revealed that the DEAD box family proteins DDX39A and DDX39B transport circRNAs from the nucleus to the cytoplasm in a size-dependent manner [31].

3. Biological Roles of circRNAs

circRNAs can stably exist in various subcellular fractions, such as the nucleus, cytoplasm, ribosome, cytosol, and exosome, because their loop structures are not affected by the 3′-to-5′ RNA exonuclease RNase R. In general, circRNAs have independent functions from linear transcripts transcribed from the same host genes because of their longer half-lives. Increasing evidence has shown that circRNAs can associate with other regulatory factors, such as microRNAs (miRNAs) and RBPs, and participate in multiple processes, including splicing, transcription, chromatin modification, miRNA sponges, and protein decoys.

3.1. miRNA Sponges

MiRNAs are post-transcriptional regulators that directly bind to mRNAs and inhibit translation or lead to mRNA degradation [32]. In recent years, increasing evidence has suggested that circRNA–miRNA–mRNA regulatory networks are important for exploring the pathogenesis and therapeutic strategies of cancer. One of the most widely investigated functions of circRNAs is to regulate posttranscriptional gene expression by acting as miRNA sponges. These circRNAs localize in the cytoplasm and contain multiple miRNA-binding sequences [10]. CiRS-7 (also termed cerebellar degeneration-related protein 1 antisense RNA (CDR1as)) was the first identified circRNA to harbor more than 70 binding sites for miR-7. MiR-7 is a tumor-suppressive miRNA involved in several pathophysiological pathways in hepatocellular carcinoma, breast cancer, and gastric cancer [33]. CiRS-7 prevents the degradation of miR-7-targeted mRNAs by functioning as a competing endogenous RNA [34].
To date, dozens of cancer-related circRNAs have been found to participate in the occupation of miRNA response elements. Hsa_circRNA_0088036 expression is upregulated in bladder cancer tissues and promotes cancer development by competing with miR-140-3p, resulting in the induction of FOXQ1 [35]. Fang et al. reported that circRNA phenylalanyl-tRNA synthetase subunit alpha (circFARSA) interacts with miR-330 and increases cell proliferation and invasion in bladder cancer tissues [36]. Hsa_circ_0000567 can act as a sponge for miR-421, which increases cell migration and invasion by directly binding to the 3′-UTR of TMEM100 mRNA in lung adenocarcinoma [37]. Downregulation of circ_0000567 accelerates the development of lung adenocarcinoma via the hsa_circ_0000567/miR-421/TMEM100 axis. CircSYPL1 expression is upregulated in patients with hepatocellular carcinoma; circSYPL1 sponges miR-506-3p to elevate EZH2 expression and induce tumorigenesis in hepatocellular carcinoma cells [38].

3.2. Epigenetic Regulation

Several studies have shown that circRNAs are involved in epigenetic regulation, including histone and chromatin modifications. circIMMP2L mediates the malignancy of esophageal squamous cell carcinoma (ESCC) by promoting the nuclear retention of CtBP1 [39]. In the nucleus, circIMMP2L mediates the interaction between CtBP1 and HDAC1 and induces the deacetylation of histone H3 in the promoter regions of E-cadherin and p21. CircMRPS35 recruits histone acetyltransferase KAT7 to the FOXO1 and FOXO3a promoter regions, leading to the acetylation of H4K5, which facilitates the activation of FOXO1/3a transcription [40]. FOXO1/3a affects the expression of downstream genes such as p21, Twist1, and E-cadherin, resulting in the suppression of cell proliferation and invasion.

3.3. Transcription and Alternative Splicing

Nuclear circRNAs can regulate gene expression by affecting transcription and alternative splicing, whereas cytoplasmic circRNAs function through interactions with miRNAs or proteins. EIciRNAs, mainly located in the nucleus, interact with U1 snRNP and promote the RNA Pol II-mediated transcription of their parental genes [17]. CircITGA7 downregulates colorectal cancer cell proliferation via facilitating the transcription of its host gene ITGA7 [41]. Ci-ankrd52, a circular intronic RNA generated from the ANKRD52 gene, is recruited to its transcription sites to promote RNA Pol II transcription [16].
The effects of circRNAs on pre-mRNA splicing have also been well characterized. CircRPAP2, a circRNA derived from the host gene RPAP2, is expressed in breast cancer tissues [42] and inhibits the proliferation and migration of breast cancer by competing with the association between the splicing factors SRSF1 and PTK2 pre-mRNA to modify the alternative splicing pattern of PTK2 mRNA. CircURI1 directly associates with hnRNPM to modulate the alternative splicing of a subset of genes involved in cell migration, resulting in the suppression of gastric cancer metastasis [43].

3.4. Protein Decoys

Several circRNAs harbor binding sites for RBPs and act as decoys to suppress protein function. For example, circMbl is derived from the splicing factor muscleblind (mbl) locus, which harbors multiple binding sites for the MBL protein [20]. CircMbl regulates MBL function by preventing its binding to its target RNAs. CircPABPN1 binds to Hu antigen R (HuR, also known as ELAV-like RNA-binding protein (ELAVL1)) to prevent the association of HuR with PABPN1 mRNA, resulting in the suppression of the effects of HuR on PABPN1 translation [44]. Circular antisense non-coding RNA in the INK4 locus (circANRIL) interacts with pescadillo homolog 1 (PES1) to disrupt pre-rRNA processing mediated by exonuclease in vascular smooth muscle cells [45]. Thus, circANRIL can control ribosome biogenesis to induce nucleolar stress and p53 activation, resulting in the stimulation of apoptosis, which is related to atherosclerosis pathology. Circ-transportin 3 (TNPO3) acts as a protein decoy for insulin-like growth factor 2 binding protein 3 (IGF2BP3) to interfere with the MYC/SNAIL axis, thereby decreasing the proliferation and metastasis of gastric cancer [46]. Chen et al. reported that circ_0000079 associates with Fragile X-Related 1 (FXR1) to interrupt the formation of the FXR1/protein kinase C, iota (PRKCI) complex, which mediates the inhibition of cell invasion and drug resistance in non-small cell lung cancer [47].

3.5. Translation into Peptides/Proteins

Although circRNAs have been categorized as non-coding RNAs, some circRNAs that harbor the open reading frame driven by internal ribosome entry sites are potentially translated into peptides or proteins [48][49]. Circ-ZNF609 exhibits internal ribosome entry site-dependent translation and functions in myoblast proliferation [50]. Zhang et al. reported that the circ-SNF2 histone linker PHD RING helicase (SHPRH) encodes a novel protein, SHPRH-146aa [51]. This truncated protein prevents the full-length SHPRH protein from degradation by the ubiquitin-proteasome and functions as a tumor suppressor in glioblastoma. CircMAPK14-175aa, a peptide of 175 amino acids encoded by the circMAPK14 gene, reduces the nuclear translocation of MAPK14 by competitively binding to MKK6 and blocking the progression of colorectal cancer [52]. Recent studies have shown that N6-methladenosine (m6A) RNA methylation can drive translation initiation in circRNAs [53]. circRNAs containing m6A are recognized by YTHDF3 and the translation initiation factor eIF4G2. Driven by m6A modification, the m6A reader protein IGF2BP1 promotes circMAP3K4 translation into circMAP3K4-455aa in hepatocellular carcinoma [54]. The expression of circMAP3K4-455aa prevents cisplatin-induced apoptosis and is associated with a worse prognosis in hepatocellular carcinoma patients.
Since most endogenous circRNAs are not associated with ribosomes and the potency of cap-independent translation may be inefficient, further studies are needed to reveal the coding potential of circRNAs.


  1. Sanger, H.L.; Klotz, G.; Riesner, D.; Gross, H.J.; Kleinschmidt, A.K. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc. Natl. Acad. Sci. USA 1976, 73, 3852–3856.
  2. Hsu, M.T.; Coca-Prados, M. Electron microscopic evidence for the circular form of RNA in the cytoplasm of eukaryotic cells. Nature 1979, 280, 339–340.
  3. Nigro, J.M.; Cho, K.R.; Fearon, E.R.; Kern, S.E.; Ruppert, J.M.; Oliner, J.D.; Kinzler, K.W.; Vogelstein, B. Scrambled exons. Cell 1991, 64, 607–613.
  4. Cocquerelle, C.; Daubersies, P.; Majerus, M.A.; Kerckaert, J.P.; Bailleul, B. Splicing with inverted order of exons occurs proximal to large introns. EMBO J. 1992, 11, 1095–1098.
  5. Cocquerelle, C.; Mascrez, B.; Hetuin, D.; Bailleul, B. Mis-splicing yields circular RNA molecules. FASEB J. 1993, 7, 155–160.
  6. Capel, B.; Swain, A.; Nicolis, S.; Hacker, A.; Walter, M.; Koopman, P.; Goodfellow, P.; Lovell-Badge, R. Circular transcripts of the testis-determining gene Sry in adult mouse testis. Cell 1993, 73, 1019–1030.
  7. Braun, S.; Domdey, H.; Wiebauer, K. Inverse splicing of a discontinuous pre-mRNA intron generates a circular exon in a HeLa cell nuclear extract. Nucleic Acids Res. 1996, 24, 4152–4157.
  8. Pasman, Z.; Been, M.D.; Garcia-Blanco, M.A. Exon circularization in mammalian nuclear extracts. RNA 1996, 2, 603–610.
  9. Salzman, J.; Gawad, C.; Wang, P.L.; Lacayo, N.; Brown, P.O. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS ONE 2012, 7, e30733.
  10. Jeck, W.R.; Sorrentino, J.A.; Wang, K.; Slevin, M.K.; Burd, C.E.; Liu, J.; Marzluff, W.F.; Sharpless, N.E. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 2013, 19, 141–157.
  11. Memczak, S.; Jens, M.; Elefsinioti, A.; Torti, F.; Krueger, J.; Rybak, A.; Maier, L.; Mackowiak, S.D.; Gregersen, L.H.; Munschauer, M.; et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013, 495, 333–338.
  12. Westholm, J.O.; Miura, P.; Olson, S.; Shenker, S.; Joseph, B.; Sanfilippo, P.; Celniker, S.E.; Graveley, B.R.; Lai, E.C. Genome-wide analysis of drosophila circular RNAs reveals their structural and sequence properties and age-dependent neural accumulation. Cell Rep. 2014, 9, 1966–1980.
  13. Rybak-Wolf, A.; Stottmeister, C.; Glazar, P.; Jens, M.; Pino, N.; Giusti, S.; Hanan, M.; Behm, M.; Bartok, O.; Ashwal-Fluss, R.; et al. Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically Expressed. Mol. Cell 2015, 58, 870–885.
  14. Gruner, H.; Cortes-Lopez, M.; Cooper, D.A.; Bauer, M.; Miura, P. circRNA accumulation in the aging mouse brain. Sci. Rep. 2016, 6, 38907.
  15. Guo, J.U.; Agarwal, V.; Guo, H.; Bartel, D.P. Expanded identification and characterization of mammalian circular RNAs. Genome Biol. 2014, 15, 409.
  16. Zhang, Y.; Zhang, X.O.; Chen, T.; Xiang, J.F.; Yin, Q.F.; Xing, Y.H.; Zhu, S.; Yang, L.; Chen, L.L. Circular intronic long noncoding RNAs. Mol. Cell 2013, 51, 792–806.
  17. Li, Z.; Huang, C.; Bao, C.; Chen, L.; Lin, M.; Wang, X.; Zhong, G.; Yu, B.; Hu, W.; Dai, L.; et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat. Struct. Mol. Biol. 2015, 22, 256–264.
  18. Bachmayr-Heyda, A.; Reiner, A.T.; Auer, K.; Sukhbaatar, N.; Aust, S.; Bachleitner-Hofmann, T.; Mesteri, I.; Grunt, T.W.; Zeillinger, R.; Pils, D. Correlation of circular RNA abundance with proliferation--exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues. Sci. Rep. 2015, 5, 8057.
  19. Salzman, J.; Chen, R.E.; Olsen, M.N.; Wang, P.L.; Brown, P.O. Cell-type specific features of circular RNA expression. PLoS Genet. 2013, 9, e1003777.
  20. Ashwal-Fluss, R.; Meyer, M.; Pamudurti, N.R.; Ivanov, A.; Bartok, O.; Hanan, M.; Evantal, N.; Memczak, S.; Rajewsky, N.; Kadener, S. circRNA biogenesis competes with pre-mRNA splicing. Mol. Cell 2014, 56, 55–66.
  21. Starke, S.; Jost, I.; Rossbach, O.; Schneider, T.; Schreiner, S.; Hung, L.H.; Bindereif, A. Exon circularization requires canonical splice signals. Cell Rep. 2015, 10, 103–111.
  22. Kramer, M.C.; Liang, D.; Tatomer, D.C.; Gold, B.; March, Z.M.; Cherry, S.; Wilusz, J.E. Combinatorial control of Drosophila circular RNA expression by intronic repeats, hnRNPs, and SR proteins. Genes Dev. 2015, 29, 2168–2182.
  23. Liang, D.; Tatomer, D.C.; Luo, Z.; Wu, H.; Yang, L.; Chen, L.L.; Cherry, S.; Wilusz, J.E. The Output of Protein-Coding Genes Shifts to Circular RNAs When the Pre-mRNA Processing Machinery Is Limiting. Mol. Cell 2017, 68, 940–954.e943.
  24. Dubin, R.A.; Kazmi, M.A.; Ostrer, H. Inverted repeats are necessary for circularization of the mouse testis Sry transcript. Gene 1995, 167, 245–248.
  25. Zhang, X.O.; Wang, H.B.; Zhang, Y.; Lu, X.; Chen, L.L.; Yang, L. Complementary sequence-mediated exon circularization. Cell 2014, 159, 134–147.
  26. Ivanov, A.; Memczak, S.; Wyler, E.; Torti, F.; Porath, H.T.; Orejuela, M.R.; Piechotta, M.; Levanon, E.Y.; Landthaler, M.; Dieterich, C.; et al. Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals. Cell Rep. 2015, 10, 170–177.
  27. Aktas, T.; Avsar Ilik, I.; Maticzka, D.; Bhardwaj, V.; Pessoa Rodrigues, C.; Mittler, G.; Manke, T.; Backofen, R.; Akhtar, A. DHX9 suppresses RNA processing defects originating from the Alu invasion of the human genome. Nature 2017, 544, 115–119.
  28. Conn, S.J.; Pillman, K.A.; Toubia, J.; Conn, V.M.; Salmanidis, M.; Phillips, C.A.; Roslan, S.; Schreiber, A.W.; Gregory, P.A.; Goodall, G.J. The RNA binding protein quaking regulates formation of circRNAs. Cell 2015, 160, 1125–1134.
  29. Errichelli, L.; Dini Modigliani, S.; Laneve, P.; Colantoni, A.; Legnini, I.; Capauto, D.; Rosa, A.; De Santis, R.; Scarfo, R.; Peruzzi, G.; et al. FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons. Nat. Commun. 2017, 8, 14741.
  30. Fei, T.; Chen, Y.; Xiao, T.; Li, W.; Cato, L.; Zhang, P.; Cotter, M.B.; Bowden, M.; Lis, R.T.; Zhao, S.G.; et al. Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. Proc. Natl. Acad. Sci. USA 2017, 114, E5207–E5215.
  31. Huang, C.; Liang, D.; Tatomer, D.C.; Wilusz, J.E. A length-dependent evolutionarily conserved pathway controls nuclear export of circular RNAs. Genes Dev. 2018, 32, 639–644.
  32. Ambros, V. The functions of animal microRNAs. Nature 2004, 431, 350–355.
  33. Kalinowski, F.C.; Brown, R.A.M.; Ganda, C.; Giles, K.M.; Epis, M.R.; Horsham, J.; Leedman, P.J. microRNA-7: A tumor suppressor miRNA with therapeutic potential. Int. J. Biochem. Cell Biol. 2014, 54, 312–317.
  34. Hansen, T.B.; Jensen, T.I.; Clausen, B.H.; Bramsen, J.B.; Finsen, B.; Damgaard, C.K.; Kjems, J. Natural RNA circles function as efficient microRNA sponges. Nature 2013, 495, 384–388.
  35. Yang, J.; Qi, M.; Fei, X.; Wang, X.; Wang, K. Hsa_circRNA_0088036 acts as a ceRNA to promote bladder cancer progression by sponging miR-140-3p. Cell Death Dis. 2022, 13, 322.
  36. Fang, C.; Huang, X.; Dai, J.; He, W.; Xu, L.; Sun, F. The circular RNA circFARSA sponges microRNA-330-5p in tumor cells with bladder cancer phenotype. BMC Cancer 2022, 22, 373.
  37. Hong, Y.; Si, J.; Xiao, B.; Xiong, Y.; Dai, C.; Yang, Y.; Li, S.; Ma, Y. circ_0000567/miR-421/TMEM100 Axis Promotes the Migration and Invasion of Lung Adenocarcinoma and Is Associated with Prognosis. J. Cancer 2022, 13, 1540–1552.
  38. Lei, D.; Wang, T. circSYPL1 Promotes the Proliferation and Metastasis of Hepatocellular Carcinoma via the Upregulation of EZH2 Expression by Competing with hsa-miR-506-3p. J. Oncol. 2022, 2022, 2659563.
  39. Liang, Y.; Mao, Q.; Wang, L.; Xia, W.; Chen, B.; Wang, H.; Li, R.; Xu, L.; Jiang, F.; Dong, G. circIMMP2L promotes esophageal squamous cell carcinoma malignant progression via CtBP1 nuclear retention dependent epigenetic modification. Clin. Transl. Med. 2021, 11, e519.
  40. Jie, M.; Wu, Y.; Gao, M.; Li, X.; Liu, C.; Ouyang, Q.; Tang, Q.; Shan, C.; Lv, Y.; Zhang, K.; et al. CircMRPS35 suppresses gastric cancer progression via recruiting KAT7 to govern histone modification. Mol. Cancer 2020, 19, 56.
  41. Li, X.; Wang, J.; Zhang, C.; Lin, C.; Zhang, J.; Zhang, W.; Zhang, W.; Lu, Y.; Zheng, L.; Li, X. Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7. J. Pathol. 2018, 246, 166–179.
  42. Yu, Y.; Fang, L. CircRPAP2 regulates the alternative splicing of PTK2 by binding to SRSF1 in breast cancer. Cell Death Discov. 2022, 8, 152.
  43. Wang, X.; Li, J.; Bian, X.; Wu, C.; Hua, J.; Chang, S.; Yu, T.; Li, H.; Li, Y.; Hu, S.; et al. CircURI1 interacts with hnRNPM to inhibit metastasis by modulating alternative splicing in gastric cancer. Proc. Natl. Acad. Sci. USA 2021, 118, e2012881118.
  44. Abdelmohsen, K.; Panda, A.C.; Munk, R.; Grammatikakis, I.; Dudekula, D.B.; De, S.; Kim, J.; Noh, J.H.; Kim, K.M.; Martindale, J.L.; et al. Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1. RNA Biol. 2017, 14, 361–369.
  45. Holdt, L.M.; Stahringer, A.; Sass, K.; Pichler, G.; Kulak, N.A.; Wilfert, W.; Kohlmaier, A.; Herbst, A.; Northoff, B.H.; Nicolaou, A.; et al. Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans. Nat. Commun. 2016, 7, 12429.
  46. Yu, T.; Ran, L.; Zhao, H.; Yin, P.; Li, W.; Lin, J.; Mao, H.; Cai, D.; Ma, Q.; Pan, X.; et al. Circular RNA circ-TNPO3 suppresses metastasis of GC by acting as a protein decoy for IGF2BP3 to regulate the expression of MYC and SNAIL. Mol. Ther. Nucleic Acids 2021, 26, 649–664.
  47. Chen, C.; Zhang, M.; Zhang, Y. Circ_0000079 Decoys the RNA-Binding Protein FXR1 to Interrupt Formation of the FXR1/PRCKI Complex and Decline Their Mediated Cell Invasion and Drug Resistance in NSCLC. Cell Transplant. 2020, 29, 963689720961070.
  48. Chen, C.Y.; Sarnow, P. Initiation of Protein Synthesis by the Eukaryotic Translational Apparatus on Circular RNAs. Science 1995, 268, 415–417.
  49. Chen, C.-K.; Cheng, R.; Demeter, J.; Chen, J.; Weingarten-Gabbay, S.; Jiang, L.; Snyder, M.P.; Weissman, J.S.; Segal, E.; Jackson, P.K.; et al. Structured elements drive extensive circular RNA translation. Mol. Cell 2021, 81, 4300–4318.e4313.
  50. Legnini, I.; Di Timoteo, G.; Rossi, F.; Morlando, M.; Briganti, F.; Sthandier, O.; Fatica, A.; Santini, T.; Andronache, A.; Wade, M.; et al. Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis. Mol. Cell 2017, 66, 22–37.e29.
  51. Zhang, M.; Huang, N.; Yang, X.; Luo, J.; Yan, S.; Xiao, F.; Chen, W.; Gao, X.; Zhao, K.; Zhou, H.; et al. A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis. Oncogene 2018, 37, 1805–1814.
  52. Wang, L.; Zhou, J.; Zhang, C.; Chen, R.; Sun, Q.; Yang, P.; Peng, C.; Tan, Y.; Jin, C.; Wang, T.; et al. A novel tumour suppressor protein encoded by circMAPK14 inhibits progression and metastasis of colorectal cancer by competitively binding to MKK6. Clin. Transl. Med. 2021, 11, e613.
  53. Yang, Y.; Fan, X.; Mao, M.; Song, X.; Wu, P.; Zhang, Y.; Jin, Y.; Yang, Y.; Chen, L.-L.; Wang, Y.; et al. Extensive translation of circular RNAs driven by N6-methyladenosine. Cell Res. 2017, 27, 626–641.
  54. Duan, J.-L.; Chen, W.; Xie, J.-J.; Zhang, M.-L.; Nie, R.-C.; Liang, H.; Mei, J.; Han, K.; Xiang, Z.-C.; Wang, F.-W.; et al. A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma. Mol. Cancer 2022, 21, 93.
Subjects: Cell Biology
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to : , , ,
View Times: 233
Revisions: 2 times (View History)
Update Date: 12 Aug 2022